FIELD: pharmaceuticals.
SUBSTANCE: present invention provides a pharmaceutical composition comprising a pyrrole-fused six-member heterocyclic compound or a pharmaceutically acceptable salt thereof. In particular, the invention provides a pharmaceutical composition, including 5-(2-diethylaminoethyl)-2-(5-fluoro-2-oxo-1,2-dihydroindole-3-ylidenemethyl)-3-methyl-1,5,6,7-tetrahydropyrrolo[3,2-c]pyridin-4-one or its pharmaceutically acceptable salt and at least one water-soluble filler.
EFFECT: pharmaceutical composition of the invention is characterized by rapid dissolution and high stability.
12 cl, 4 tbl, 11 ex, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION CONTAINING OLMESARTAN MEDOXOMIL AND ROSUVASTATIN OR ITS SALT | 2013 |
|
RU2616516C2 |
| STABLE PHARMACEUTICAL COMPOSITION CONTAINING WATER-SOLUBLE VINFLUNINE SALT | 2008 |
|
RU2462248C2 |
| PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN LOBEGLITAZONE FOR ORAL ADMINISTRATION | 2015 |
|
RU2709526C2 |
| PHARMACEUTICAL COMPOSITIONS FOR TREATING CEREBROVASCULAR DISORDERS AND METHODS FOR PREPARING THEM | 2012 |
|
RU2559776C2 |
| SOLID DOSAGE FORMS OF PALLBOCYCLOB | 2016 |
|
RU2686840C1 |
| NEW COMPOSITION OF LAPATINIB AS A SOLID DOSAGE FORM FOR ORAL USE AND A METHOD OF ITS MANUFACTURE | 2019 |
|
RU2821950C2 |
| PHARMACEUTICAL ANTIFUNGAL COMPOSITION BASED ON A CHLOROPHENYLBUTANEDIONE DERIVATIVE AND A METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2707286C1 |
| TABLET COMPOSITION COMPRISING CINACALCET HYDROCHLORIDE | 2013 |
|
RU2662562C2 |
| SOLID MEDICINAL FORMULATION POSSESSING HISTAMINE-LIKE EFFECT AND METHOD FOR ITS PREPARING | 2006 |
|
RU2308941C1 |
| DISINTEGRATING AGENT | 1999 |
|
RU2201215C2 |
